AARTI PHARMALABS
|
AARTI PHARMALABS Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Profit Before Tax | ₹300 Cr | ₹261 Cr | ₹155 Cr | ₹0.00 Cr |
Adjustment | ₹95 Cr | ₹83 Cr | ₹52 Cr | - |
Changes In working Capital | ₹-122 Cr | ₹-32 Cr | ₹-230 Cr | ₹0.00 Cr |
Cash Flow after changes in Working Capital | ₹273 Cr | ₹312 Cr | ₹-23 Cr | - |
Cash Flow from Operating Activities | ₹216 Cr | ₹250 Cr | ₹-44 Cr | - |
Cash Flow from Investing Activities | ₹-215 Cr | ₹-158 Cr | ₹-139 Cr | - |
Cash Flow from Financing Activities | ₹9.72 Cr | ₹-163 Cr | ₹260 Cr | - |
Net Cash Inflow / Outflow | ₹12 Cr | ₹-71 Cr | ₹78 Cr | - |
Opening Cash & Cash Equivalents | ₹12 Cr | ₹83 Cr | ₹5.33 Cr | ₹0.25 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - |
Closing Cash & Cash Equivalent | ₹24 Cr | ₹12 Cr | ₹83 Cr | ₹0.25 Cr |
Compare Cashflow Statement of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹8,247.8 Cr | 3.5% | 27.6% | 55% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,680.0 Cr | 0.2% | -8.3% | 15.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,532.0 Cr | -1.9% | 8.6% | 55.9% | Stock Analytics | |
CIPLA | ₹118,315.0 Cr | -1.3% | -5.5% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,421.0 Cr | -0.5% | -4.2% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,453.0 Cr | 0.7% | 5.8% | 6.1% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | 3.5% |
27.6% |
55% |
SENSEX | -0.3% |
1.5% |
8% |
You may also like the below Video Courses